Bortezomib administration with severe hyperbilirubinemia caused by hepatic plasma cell infiltration: a case report.
Winship Cancer Institute of Emory University, Atlanta, GA, USA.
Nicole
N
Wilson
Minal
M
Surati
Bruce F
BF
Walker
Jonathan L
JL
Kaufman
R Donald
RD
Harvey
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001706:Biopsy; D001897:Boronic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D000069286:Bortezomib; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology*; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D010950:Plasma Cells / Q000473:pathology*; D011719:Pyrazines / Q000008:administration & dosage* / Q000009:adverse effects
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib